Crown Bioscience

Company Overview

Crown Bioscience is a multinational contract research organization (CRO) that works with pharmaceutical and biotech firms to advance medication development and discovery in oncology and immuno-oncology to enhance human health. The company provides various integrated solutions, such as clinical trial assistance, translational platforms, and preclinical research services. With over 600 models spanning 22 disease indications, Crown Bioscience provides tumor organoid services utilizing cutting-edge Hubrecht Organoid Technology and the world’s biggest commercially available patient-derived xenograft (PDX) collection.

The company offers a wide range of platforms and services, such as advanced laboratory services that span the whole drug development timeline and in vivo, in vitro, ex vivo, and in silico methodologies. it keeps a sizable biobank of human and liquid biospecimens with clinical histories. With 11 locations in the U.S., Europe, and Asia-Pacific, including labs approved by the International Organization for Standardization (ISO) and the College of American Pathologists (CAP), the company guarantees the h33ighest standards of dependability and quality in research settings.

Company's Business Segments

• Preclinical and Translational Research Services : The company offers contract research organization (CRO) services for drug discovery and development, focusing on oncology, immuno-oncology, and immune-mediated inflammatory diseases.